Raymond James Upgrades Quidel Corporation to Outperform

Brokerage firm Raymond James Upgrades its rating on Quidel Corporation(NASDAQ:QDEL). The shares have been rated Outperform. Previously, the analysts had a Market Perform rating on the shares. The rating by Raymond James was issued on Jun 13, 2016.

Quidel Corporation (QDEL) shares turned negative on Fridays trading session with the shares closing down -0.33 points or -1.84% at a volume of 2,19,863. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $17.92. The peak price level was also seen at $17.92 while the days lowest was $17.47. Finally the shares closed at $17.58. The 52-week high of the shares is $24.59 while the 52-week low is $13.2105. According to the latest information available, the market cap of the company is $568 M.

Quidel Corporation(QDEL) last announced its earnings results on Apr 27, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $50.32M. Analysts had an estimated revenue of $49.21M. Earnings per share were $0.02. Analysts had estimated an EPS of $-0.07.

Several Insider Transactions has been reported to the SEC. On Feb 23, 2016, Douglas C Bryant (CEO) purchased 3,700 shares at $13.91 per share price.Also, On Dec 3, 2015, John Tamerius (SVP, Strat & Ext Affairs) sold 21,109 shares at $21.83 per share price.

Quidel Corporation is engaged in the development manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases women’s health and gastrointestinal diseases. The Company sells its products directly to end users and distributors in each case for professional use in physician offices hospitals clinical laboratories reference laboratories universities retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors and a direct sales force. Internationally it sells and markets primarily through distributor arrangements. Its diagnostic solutions are used in the detection and diagnosis of many critical diseases and other medical conditions including infectious diseases women’s health autoimmune diseases bone health thyroid diseases and fecal occult blood.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Quidel Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Quidel Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.